Lawrence A. Leiter
Impact in
- Endocrinology, Diabetes and Metabolism top 0.01%
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
-
- Diabetes Treatment and Management 180
- Diabetes Management and Research 56
- Diabetes, Cardiovascular Risks, and Lipoproteins 52
- Diet, Metabolism, and Disease 31
- Surgery 183
- Lipoproteins and Cardiovascular Health 143
- Co-authors
- Deepak L. Bhatt (80 shared papers)Darren K. McGuire (50 shared papers)Ofri Mosenzon (45 shared papers)Kausik Kumar Ray (62 shared papers)Stephen D. Wiviott (15 shared papers)Marc Steven Sabatine (43 shared papers)John P.H. Wilding (41 shared papers)John L. Sievenpiper (72 shared papers)
- Journals
- Diabetes Care (45 papers)Canadian Journal of Cardiology (44 papers)Diabetes Obesity and Metabolism (38 papers)Canadian Journal of Diabetes (27 papers)Circulation (26 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Lawrence A. Leiter
653 papers receiving 66.9k citations
Lawrence A. Leiter's Hit Papers
Peers
Comparison fields: 5 of 191
- Endocrinology, Diabetes and Metabolism 34.0k
- Cardiology and Cardiovascular Medicine 11.8k
- Surgery 18.8k
- Nephrology 2.1k
- Physiology 6.4k
Countries citing papers authored by Lawrence A. Leiter
This map shows the geographic impact of Lawrence A. Leiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence A. Leiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence A. Leiter more than expected).
Fields of papers citing papers by Lawrence A. Leiter
This network shows the impact of papers produced by Lawrence A. Leiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence A. Leiter. The network helps show where Lawrence A. Leiter may publish in the future.
Co-authors
The 25 scholars most cited alongside Lawrence A. Leiter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 675 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes Hit paper breakdown → | 2016 | 5193 |
| 2 | Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes Hit paper breakdown → | 2018 | 4888 |
| 3 | Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus Hit paper breakdown → | 2013 | 2822 |
| 4 | Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hit paper breakdown → | 2019 | 2307 |
| 5 | SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials Hit paper breakdown → | 2018 | 2160 |
| 6 | Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome Hit paper breakdown → | 2012 | 1686 |
| 7 | Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial Hit paper breakdown → | 2018 | 1430 |
| 8 | Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure Hit paper breakdown → | 2020 | 1427 |
| 9 | Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol Hit paper breakdown → | 2020 | 1208 |
| 10 | Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management Hit paper breakdown → | 2015 | 1137 |
| 11 | 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult Hit paper breakdown → | 2016 | 974 |
| 12 | Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease Hit paper breakdown → | 2020 | 932 |
| 13 | Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol Hit paper breakdown → | 2017 | 814 |
| 14 | Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease Hit paper breakdown → | 2016 | 683 |
| 15 | Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia Hit paper breakdown → | 2020 | 661 |
| 16 | Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial Hit paper breakdown → | 2013 | 647 |
| 17 | Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus Hit paper breakdown → | 2019 | 633 |
| 18 | 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults Hit paper breakdown → | 2021 | 627 |
| 19 | 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations Hit paper breakdown → | 2009 | 623 |
| 20 | 2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult Hit paper breakdown → | 2013 | 620 |
About Lawrence A. Leiter
Lawrence A. Leiter is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Cardiology and Cardiovascular Medicine, Nutrition and Dietetics and Physiology, having authored 675 papers that have together received 70.3k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (180 papers), Lipoproteins and Cardiovascular Health (143 papers), Diabetes Management and Research (56 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (52 papers), Diet and metabolism studies (44 papers), Metabolism, Diabetes, and Cancer (38 papers), Diet, Metabolism, and Disease (31 papers) and Health Systems, Economic Evaluations, Quality of Life (28 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (34.0k citations), Cardiology and Cardiovascular Medicine (11.8k citations), Surgery (18.8k citations), Nephrology (2.1k citations) and Physiology (6.4k citations). Lawrence A. Leiter has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Deepak L. Bhatt, Darren K. McGuire, Ofri Mosenzon, Kausik Kumar Ray, Stephen D. Wiviott, Marc Steven Sabatine, John P.H. Wilding, John L. Sievenpiper, Avivit Cahn and Marc P. Bonaca. Their work appears in journals such as Diabetes Care, Canadian Journal of Cardiology, Diabetes Obesity and Metabolism, Canadian Journal of Diabetes and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.